Frontera Therapeutics Inc

Call
Website
1 Patriots Park Ste 2
Bedford, MA 01730
+1 (617) 546-7300
https://fronteratherapeutics.com
Frontera Therapeutics is a leading clinical-stage biotechnology company based in Bedford, Town of, MA. They specialize in developing innovative gene therapy medicines to enhance the lives of patients across various disease areas. Frontera's APEX Technology Manufacturing Platform utilizes advanced adeno-associated virus (AAV) gene expression systems, clinically validated AAV vectors, and efficient CMC processes to expedite the development of novel gene therapy products with lower costs and faster speed-to-market. With a world-class team and state-of-the-art GMP facilities, Frontera is focused on addressing not only rare monogenic disorders but also larger patient markets including Ophthalmology, Hematology, Cardiovascular, and Metabolic Diseases.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Business services, nec, nec, Services, nec, nec, Real estate managers

Aviceda Therapeutics

Aviceda Therapeutics, based in Cambridge, MA, focuses on harnessing the body's natural immune system to modulate inflammation. The company utilizes highly selective ligands designed for maximum specificity towards targeted immune cells and diseases. By employing nature's design, Aviceda Therapeutics aims to develop innovative therapeutic solutions that enhance immune responses. Their approach emphasizes precision in targeting, which is crucial for effectively addressing various health conditions. Generated from the website
Drugs acting on the respiratory system, Blood derivatives, Surgical instruments and apparatus

Relay Therapeutics

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.
Drugs acting on the respiratory system, Vitamin, nutrient, and hematinic preparations for human use

Akebia Therapeutics, Inc

Akashi Therapeutics, based in Cambridge, is a global biopharmaceutical company with a focus on developing innovative therapies for individuals affected by rare disorders. The company's mission is to create life-changing treatments that address the unmet medical needs of those living with rare diseases, aiming to improve the quality of life for patients worldwide. Generated from their website's infomation
United States›Massachusetts›Bedford›Frontera Therapeutics Inc

Partial Data by Infogroup (c) 2025. All rights reserved.